The effect of probiotic on prevention of ventilator associated pneumonia

The effect of probiotic on prevention of ventilator associated pneumonia in the patients admitted to ICU

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201707227752N10

Enrollment

164

Registered

2017-08-04

Start date

2017-01-04

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventilator associated pneumonia. Pneumonia, organism unspecified

Interventions

Intervention 1: Intervention group: the consumption of familact with the dose of 500 mg twice a day. Intervention 2: Control group: the consumption of placebo the the dose of 500 mg twice a days for

Prevention

Intervention group: the consumption of familact with the dose of 500 mg twice a day.

Control group: the consumption of placebo the the dose of 500 mg twice a days for 10 days.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: written consent from the family member; continuance of mechanical ventilation at least 72 hours; maximum 48 hours from intubation; start nutrition after 48 hours; no pneumonia; no tracheostomy Exclusion criteria: pregnancy; replacement of heart valve; vascular graft; history of rheumatoid fever; endocarditis; pancreatitis; fracture of base of skull; discharge less than one week.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Ventilator associated pneumonia. Timepoint: 3 days after intervention. Method of measurement: CPIS scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParviz Amrimaleh

Babol University of Medical Sciences

pamrimaleh@gmail.com+98 11 3223 8284

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026